BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 18064419)

  • 1. Presynaptic adenosine and P2Y receptors.
    Gonçalves J; Queiroz G
    Handb Exp Pharmacol; 2008; (184):339-72. PubMed ID: 18064419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATP and adenosine inhibit transmitter release at the frog neuromuscular junction through distinct presynaptic receptors.
    Giniatullin RA; Sokolova EM
    Br J Pharmacol; 1998 Jun; 124(4):839-44. PubMed ID: 9690879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The P2Y(1) and P2Y(12) receptors mediate autoinhibition of transmitter release in sympathetic innervated tissues.
    Quintas C; Fraga S; Gonçalves J; Queiroz G
    Neurochem Int; 2009 Dec; 55(7):505-13. PubMed ID: 19447154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2.
    Baraldi PG; Romagnoli R; Tabrizi MA; Bovero A; Preti D; Fruttarolo F; Moorman AR; Borea PA
    Farmaco; 2005 Mar; 60(3):185-202. PubMed ID: 15784237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of presynaptic purinoceptors to modulate noradrenaline release from sympathetic nerves in human dental pulp.
    Parker DA; Marino V; Krishna M; Narayanan A; de la Lande IS
    Arch Oral Biol; 2000 Oct; 45(10):827-31. PubMed ID: 10973556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of the P2 receptors.
    Boeynaems JM; Communi D; Gonzalez NS; Robaye B
    Semin Thromb Hemost; 2005 Apr; 31(2):139-49. PubMed ID: 15852217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purines and pain mechanisms: recent developments.
    Liu XJ; Salter MW
    Curr Opin Investig Drugs; 2005 Jan; 6(1):65-75. PubMed ID: 15675605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of purines on calcium-independent acetylcholine release at the mouse neuromuscular junction.
    Veggetti M; Muchnik S; Losavio A
    Neuroscience; 2008 Jul; 154(4):1324-36. PubMed ID: 18534762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging roles for P2X1 receptors in platelet activation.
    Mahaut-Smith MP; Tolhurst G; Evans RJ
    Platelets; 2004 May; 15(3):131-44. PubMed ID: 15203715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nucleotide receptors--structure and function, history and perspectives].
    Barańska J
    Postepy Biochem; 2014; 60(4):424-37. PubMed ID: 25807822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A putative osmoreceptor system that controls neutrophil function through the release of ATP, its conversion to adenosine, and activation of A2 adenosine and P2 receptors.
    Chen Y; Shukla A; Namiki S; Insel PA; Junger WG
    J Leukoc Biol; 2004 Jul; 76(1):245-53. PubMed ID: 15107462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purines and neutrophil leukocytes.
    Fredholm BB
    Gen Pharmacol; 1997 Mar; 28(3):345-50. PubMed ID: 9068971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current state of purinoceptor research.
    Burnstock G
    Pharm Acta Helv; 1995 Mar; 69(4):231-42. PubMed ID: 7651967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiological effects of ATP on brain neurones.
    Illes P; Nieber K; Nörenberg W
    J Auton Pharmacol; 1996 Dec; 16(6):407-11. PubMed ID: 9131427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P2X and P2Y receptors as possible targets of therapeutic manipulations in CNS illnesses.
    Köles L; Furst S; Illes P
    Drug News Perspect; 2005 Mar; 18(2):85-101. PubMed ID: 15883618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purinergic regulation of acetylcholine release.
    Ribeiro JA; Cunha RA; Correia-de-Sá P; Sebastião AM
    Prog Brain Res; 1996; 109():231-41. PubMed ID: 9009712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptors for purines and pyrimidines.
    Ralevic V; Burnstock G
    Pharmacol Rev; 1998 Sep; 50(3):413-92. PubMed ID: 9755289
    [No Abstract]   [Full Text] [Related]  

  • 18. Purinergic receptors on insulin-secreting cells.
    Hillaire-Buys D; Chapal J; Bertrand G; Petit P; Loubatières-Mariani MM
    Fundam Clin Pharmacol; 1994; 8(2):117-27. PubMed ID: 8020870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purinergic dysfunction in mania: an integrative model.
    Machado-Vieira R; Lara DR; Souza DO; Kapczinski F
    Med Hypotheses; 2002 Apr; 58(4):297-304. PubMed ID: 12027524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine and ATP: progress in their receptors' structures and functions.
    Khakh BS; Kennedy C
    Trends Pharmacol Sci; 1998 Feb; 19(2):39-41. PubMed ID: 9550938
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.